Treovir LLC Profile last edited on: 3/5/21
CAGE: 8C8X4
UEI: P3MKE8JK22Q8
Business Identifier: NO Business Identifier is currently available for this company. 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 04
County: Montgomery
Congr. District: 04
County: Montgomery
Public Profile
Defined in Cruncbase only as a biological research company.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
Less than .5MVC funded?
YesPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2022 | 2 | NIH | $1,722,769 | |
| Project Title: Phase II Clinical Trial of G207 HSV to Treat Children with High Grade Gliomas | ||||
Key People / Management
Michael Christini -- CEO
G Yancey Gillespie -- Founder and Cheif Scientific Officer
G Yancey Gillespie -- Founder and Cheif Scientific Officer
Company News
There are no news available.
